Related Experiment Video
Updated: Oct 5, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Evaluation of Medication Package Inserts in Ethiopia
Haftom Gebregergs Hailu1, Mengistie Yirsaw Gobezie2, Khalid Beshir Tuem1
1Department of Pharmacology and Toxicology, School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Medication package inserts (MPIs) in Ethiopia lack crucial safety information and local language translations. Regulatory bodies must enforce stricter standards for complete and accessible patient medication information.
Area of Science:
- Pharmaceutical Sciences
- Public Health
- Health Communication
Background:
- Accurate medication information is vital for patient safety and adherence.
- Incomplete patient knowledge can lead to poor treatment outcomes.
- This study assesses medication package inserts (MPIs) in Ethiopia.
Purpose of the Study:
- To evaluate the presentation and completeness of MPIs in the Ethiopian market.
- To identify deficiencies in patient medication information.
- To inform regulatory improvements for medication safety.
Main Methods:
- Cross-sectional document review of MPIs.
- Data collected in February-March 2019.
- Included all MPIs authorized by the Ethiopian Food and Drug Authority (EFDA).
Main Results:
- The average completeness score of 200 MPIs was 18.39 ± 4.30.
- Only 49.5% provided special warnings/precautions; few offered instructions for liquid conversion (4.8%) or tablet splitting (8.7%).
- Local language translation was present in only 1.0% of MPIs.
Conclusions:
- MPIs in Ethiopia are incomplete, lacking vital safety and usage details.
- There is a significant need for improved regulatory oversight and standardization of MPIs.
- Enhancing MPI content and accessibility is crucial for patient safety and effective medication use.
Related Concept Videos
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Therapy
Antianxiety Medications
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation

